 |
 |

Hepatitis B Virus VaccineAn Analysis of Its Potential Use in Medical Workers
John D. Hamilton, MD
JAMA. 1983;250(16):2145-2150.
Abstract
At the Duke University Medical Center, Durham, NC, there are approximately ten recognized hepatitis B virus (HBV) infections per year in employees. The hospital's hepatitis control program costs $91,995 per year, including costs for workman's compensation, hyperimmune globulin, laboratory tests, lost revenue, liability, personnel, and medical treatment. A program to immunize high-risk medical center personnel and to accommodate residual HBV problems in nonimmunized employees would cost $206,304 in the first year. By seven years the cumulative costs of an immunization program would equal those without a program and at ten years would be cost saving ($746,742 with program v $919,950 without a program). Given certain assumptions, HBV vaccine is a cost-beneficial alternative for a major employee health hazard.
(JAMA 1983;250:2145-2150)
Author Affiliations
From the Department of Medicine, Durham Veterans Administration Medical Center, and Duke University Medical Center, Durham, NC.
Footnotes
Reprint requests to Veterans Administration Medical Center, 508 Fulton St, Durham, NC 27705 (Dr Hamilton).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hepatitis B Virus Vaccine: Cost-Benefit Analysis of its Use in a Children's Hospital
Hicks et al.
CLIN PEDIATR 1989;28:359-365.
ABSTRACT
Immunization Policies and Vaccine Coverage Among Adults: The Risk for Missed Opportunities
WILLIAMS et al.
ANN INTERN MED 1988;108:616-625.
ABSTRACT
Viral Hepatitis: A Population-Based Study in Rochester, Minn, 1971-1980
Osmon et al.
Arch Intern Med 1987;147:1235-1240.
ABSTRACT
Clinical Viral Hepatitis B Among Minnesota Hospital Personnel: Results of a Ten-Year Statewide Survey
Osterholm and Garayalde
JAMA 1985;254:3207-3212.
ABSTRACT
Acute Clinical Outcomes of Hepatitis B Infection
Lohiya and Lohiya
JAMA 1984;252:898-898.
ABSTRACT
Costs and Benefits of Hepatitis Prophylaxis
Egilman and Lichty
JAMA 1984;251:2794-2794.
ABSTRACT
|